You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-p53 antibody [PAb 1801] (ab28)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab28? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab28 has been referenced in 6 publications.

  1. Masgras I et al. Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem 287:9845-54 (2012). WB; Human. PubMed: 22311974
  2. Rajagopalan S et al. Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2. Proc Natl Acad Sci U S A 107:8587-92 (2010). WB; Human. PubMed: 20421506
  3. Foster PA et al. STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells. Anticancer Res 29:3751-7 (2009). PubMed: 19846905
  4. Solé M et al. p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1. Biochim Biophys Acta 1783:1085-94 (2008). WB; Rat. PubMed: 18348872
  5. Kotecha M et al. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78. Mol Cancer Ther 7:1319-28 (2008). WB; Mouse. PubMed: 18483319
  6. Geddie ML et al. Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensors. J Biol Chem 280:35641-6 (2005). PubMed: 16118206

Publishing research using ab28? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"